Results 141 to 150 of about 47,448 (187)

The therapeutic promise of probiotic <i>Bacteroides fragilis</i> (BF839) in cancer immunotherapy. [PDF]

Front Microbiol
Peng K, Li Y, Yang Q, Yu P, Zeng T, Lin C, Deng Y, Chen J.   +7 more
europepmc   +1 more source

Genomic alterations in Bacteroides fragilis favor adaptation in colorectal cancer microenvironment. [PDF]

BMC Genomics
Yang H, Gan Y, Jiang S, Zhu X, Xia Y, Gong D, Xie X, Gong Y, Zhang Y, Lei Q, Wang M, Li J.   +11 more
europepmc   +1 more source

Biological Mechanisms of Enterotoxigenic <i>Bacteroides fragilis</i> Toxin: Linking Inflammation, Colorectal Cancer, and Clinical Implications. [PDF]

Toxins (Basel)
Jasemi S, Molicotti P, Fais M, Cossu I, Simula ER, Sechi LA.   +5 more
europepmc   +1 more source

<i>Bacteroides fragilis</i> and propionate synergize with low-dose methimazole to treat Graves' disease. [PDF]

Microbiol Spectr
Zhang X, Pan Q, Yao G, Kong D, Chen H, Zhang Q, Wang Z.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Bacteroides fragilis Meningitis

Clinical Infectious Diseases, 1987
Bacteroides fragilis is a rare cause of bacterial meningitis. In the antibiotic era nine cases have been reported. Seven of these nine cases occurred in premature infants and neonates. Of the nine patients with B. fragilis meningitis, two died, four survived with neurologic sequelae, and three survived without sequelae. Predisposing conditions included
Henry M Feder
exaly   +3 more sources

Enterotoxigenic Bacteroides fragilis

Clinical Infectious Diseases, 1995
Enterotoxigenic Bacteroides fragilis (ETBF) has been recently associated with watery diarrheal disease in livestock and young children. These strains of B. fragilis secrete an extracellular heat-labile protein toxin with a mess of approximately 20 kD. This toxin has been shown to have two major biological activities: stimulation of secretion in ligated
C L, Sears, L L, Myers, A, Lazenby, R L, Van Tassell   +3 more
openaire   +2 more sources

Bacteroides fragilis Endocarditis

Southern Medical Journal, 1988
We recently diagnosed and treated an unusual case of primary endocarditis due to Bacteroides fragilis, for which no underlying etiology was found. Antibiotic treatment involved multiple parenteral and oral antibiotics, and sensitivity studies allowed choice of antibiotics. Despite complications, the patient was cured.
R T, Jackson, A C, Dopp
openaire   +2 more sources

Bacteroides Fragilis

Acta Clinica Belgica, 1973
SummaryBacteroides fragilis is a frequent causative agent of serious infections occurring after major surgery or in immuno depressed patients.Technical details concerning its isolation and identification are presented.The nature of the necessary growth factor seems to be the tetrapyrrolstructure.
G. Wauters, J. Gigi
openaire   +1 more source

The toxins of Bacteroides fragilis

Toxicon, 2001
Bacteroides fragilis are both key commensals and important human pathogens. Particular strains of B. fragilis, termed enterotoxigenic B. fragilis (ETBF), are recently identified enteric pathogens of children and adults. These strains are distinguished by secretion of a 20kDa metalloprotease toxin (B.
openaire   +2 more sources

Enterotoxigenic Bacteroides fragilis

Current Infectious Disease Reports, 2008
Bacteroides fragilis is a minor component of the microbial flora of the intestine but the most frequent disease--causing anaerobe. Virulence characteristics are its capsule, which induces abscess formation, and the production of fragilysin, a Zn-metalloprotease.
openaire   +2 more sources